These results indicate that the growth-inhibitory effects of FKA on HER2-overexpressing or minimally-expressing breast cancer cells is associated with a G1 or M phase arrest, respectively, and that the FKA induced G2M arrest in HER2-overexpressing breast cancer cells is independent of p53 status. Here, TP53 is linked to breast cancer.